Paracetamol/ Pseudoephedrine/ Codeine
Indications
Registered South African indications:
- Colds and influenza
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe hepatic impairment
Cautions
- Mild to moderate hepatic impairment
- Renal impairment
Pseudoephedrine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe renal impairment
- Cardiovascular disease
- Children younger than 12 years
- Phaeochromocytoma
- Diabetes mellitus
- Hyperthyroidism
- Closed angle glaucoma
- Coadministration with monoamine oxidase inhibitors or within 14 days of their use
- Coadministration with other sympathomimetic decongestants
- Coadministration with beta blockers
Cautions
- Breastfeeding
- Mild to moderate renal impairment
- Severe hepatic impairment
- Elderly
- Enlarged prostate
- Bladder dysfunction
- Seizure disorders
Codeine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Breastfeeding
- Severe hepatic impairment
- Acute respiratory depression
- Obstructive airways disease
- Acute alcoholism
- Raised intracranial pressure or head injury
- Comatose patients
- Conditions where inhibition of peristalsis is to be avoided
- CYP2D6 ultra-rapid metabolisers
Cautions
- Pregnancy
- Renal impairment
- Mild to moderate hepatic impairment
- Elderly
- Debilitated
- Asthma and decreased respiratory reserve
- Misuse, abuse potential or dependence
- Dependency and addiction with prolonged and continuous use
- Hypotension
- Hypothyroidism
- Prostatic hypertrophy
- Urethral stricture
- Adrenocortical insufficiency
- Inflammatory or obstructive bowel disorders
- Shock
- Convulsive disorders
- Myasthenia gravis
- Children with compromised respiratory function
- Biliary tract disorders
- May impair the ability to drive and operate machinery
Adult dosage
Forms avail. in SA and covered in this monograph: tab
Symptomatic relief of colds and influenza
- Mild to moderate pain
- Nasal, sinus and Eustachian tube mucal congestion
- Fever
Paracetamol/ Pseudoephedrine/ Codeine
500/ 30/ 8 (mg)
- Oral (tab): 2 tab, 6-8hrly; Max: 8 tab/24hrs
Paediatric dosage
Not established for use in children below 12 years
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
Breastfeeding
- Mild to moderate: Caution; no dose adjustment recommended (Pseudoephedrine)
- Severe: Contraindicated (Pseudoephedrine)
Hepatic Impairment
Elderly
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
Respiratory Disorders
- Bronchospasm
Hepatobiliary Disorders
- Hepatic dysfunction
Immune, Blood and Lymphatic System Disorders
- Anaphylaxis
- Cutaneous hypersensitivity reactions
- Angioedema
- Stevens-Johnson syndrome
- Thrombocytopenia
- Agranulocytosis
- Methaemoglobinaemia
Pseudoephedrine
Central Nervous System Disorders
- Hallucinations
- Insomnia
- Anxiety
- Restlessness
- Irritability
- Psychosis
- Headache
- Seizures
- Vertigo
- Ataxia
- Fatigue
- Tremor
Cardiovascular Disorders
- Tachycardia
- Palpitations
- Arrhythmias
- Hypertension
- Impaired circulation to the extremities
Respiratory Disorders
- Dry throat
- Dry nose
- Dyspnoea
- Nasal congestion
- Pharyngeal oedema
- Thickening of bronchial secretions
- Wheezing
Gastrointestinal Disorders
- Dry mouth
- Nausea and vomiting
- Anorexia
- Constipation
- Diarrhoea
- Ischemic colitis
Genitourinary Disorders
- Urinary retention
- Dysuria
Skin and Subcutaneous Tissue Disorders
- Diaphoresis
- Skin photosensitivity
- Skin rash
- Urticaria
Immune, Blood and Lymphatic System Disorders
- Anaphylaxis
- Agranulocytosis
- Haemolytic anaemia
- Thrombocytopaenia
Sensory Disorders
- Closed angle glaucoma
- Blurred vision
- Diplopia
- Tinnitus
Codeine
Central Nervous System Disorders
- Dizziness
- Drowsiness
- Mood changes
- Euphoria
- Dysphoria
- Mental depression
- Restlessness
- Confusion
- Headache
- Raised intracranial pressure
- Hallucinations
- Nightmares
- Vertigo
Cardiovascular Disorders
- Tachycardia
- Palpitations
- Bradycardia
- Postural hypotension
- Facial flushing
- Hypotension
Respiratory Disorders
- Dyspnoea
- Respiratory depression
Gastrointestinal Disorders
- Nausea and vomiting
- Constipation
- Dry mouth
- Stomach cramps
- Pancreatitis
- Biliary spasm
Genitourinary System Disorders
- Sexual dysfunction
- Erectile dysfunction
- Decreased potency
- Decreased libido
- Difficulty with micturation
- Urinary retention
- Ureteric spasm
- Dysuria
Endocrine and Metabolic Disorders
- Hyperglycaemia
- Anorexia
Musculoskeletal Disorders
- Uncontrolled muscle movements
- Muscle rigidity
Skin and Subcutaneous Tissue Disorders
- Skin rashes
- Urticaria
- Pruritus
- Sweating
- Facial oedema
Immune System Disorders
- Maculopapular rash
- Fever
- Splenomegaly
- Lymphadenopathy
Sensory Disorders
- Blurred or double vision or other changes in vision
- Miosis
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
- Metoclopramide
- Domperidone
- Cholestyramine
- Oral anticoagulants
- Chloramphenicol
Pseudoephedrine
- Sympathomimetic agents
- Antihypertensive agents
- Monoamine oxidase inhibitors
- Volatile anaesthetics
- Cardiac glycosides
- Anticholinergic agents
- Antidepressants
- Antipsychotics
- Doxapram
- Oxytocin
- Aluminium oxide
Codeine
- Alcohol
- Anaesthetics
- Antiarrhythmic agents
- Central nervous system depressants
- Antihistamines
- Domperidone
- Metoclopramide
- Cimetidine
Monitoring
None routine
Mechanism of action
Paracetamol
Paracetamol increases the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin synthesis. It does not inhibit cyclooxygenase in peripheral tissues and, thus, has no peripheral anti-inflammatory effects.
Pseudoephedrine
Pseudoephedrine acts mainly on alpha and also on beta adrenergic receptors. It produces vasoconstriction by acting on the alpha-adrenergic receptors in the mucosa of the respiratory tract. This results in the decongestant properties of pseudoephedrine.
Codeine
Codeine is a centrally acting weak analgesic. It exerts its effect through mu opioid receptors. It resembles morphine in its pharmacodynamic actions although much weaker in its effects.
Dosage forms
- Tablet
- Syrup
Formulation
COMBINATION PREPARATIONS
Paracetamol/ Pseudoephedrine/ Codeine
Tablet 500mg/30mg/8mg
- Sinumax co (Janssen) originator
References
1. https://drive.google.com/drive/folders/0B27NqM_vidrmNDJURnktVWhVMVU (Janssen_Sinumax co_tab)
Brands & products
2 products · cached snapshot- Sinumax Co
SYRSyrup· 1 product
from R50.85| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Cofendyldiscontinued | 250 mg/5ml;mg/5ml;mg/5ml | 100 | Pharmacare Limited, Woodmead | R50.85 |
TABTablet· 1 product
from R82.75| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Sinumax With Codeinediscontinued | 500 mg;mg;mg | 20 | Janssen Pharmaceutica (Pty) Ltd | R82.75 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.